Join 100+ of your digital health and CNS clinical development peers to address the standardization and regulatory acceptance of digital tools and data analysis as endpoints in complex neurological indications, discover novel innovations for objective, sensitive, and non-invasive neurological measures, and ensure internal confidence and scalability with emerging digital technologies.
Uniting Digital Health Biopharma with CNS Clinical Drug Developers to:
1. Address the Standardization and Regulatory Acceptance of Digital Tools and Data Analysis as Endpoints in Complex Neurological Indications
2. Discover Novel Innovations for Objective, Sensitive, and Non-Invasive Neurological Measures
3. Ensure Confidence and Scalability with Emerging Digital Technologies
Read on digital-biomarkers-neurology.com
Continue reading at digital-biomarkers-neurology.com
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2023 Netspective Media LLC. All Rights Reserved.
Built on Jun 2, 2023 at 12:16pm